\-\ Texto\\:\\ \ \(0\)\
\-\ a\\ lateral\\ view\\ of\\ the\\ pharynx\\ during\\ phonation\\ \\(films\\ \\.1\\ and\\ \\.3\\)\\ shows\\ multiple\\,\\ irregular\\,\\ 2\\-4\\ mm\\ nodules\\ in\\ the\\ oropharynx\\ and\\ in\\ the\\ tonsillar\\ fossa\\.\\ \\ a\\ single\\ view\\ of\\ the\\ mid\\ esophagus\\ \\(film\\ \\.2\\)\\ shows\\ multiple\\ small\\,\\ well\\-circumscribed\\ plaques\\ aligned\\ longitudinally\\ along\\ mucosal\\ folds\\.\\ \\ barium\\ has\\ coated\\ the\\ laryngeal\\ vestibule\\ and\\ trachea\\.\ \(0\)\
\-\ candida\\ pharyngitis\\ and\\ candida\\ esophagitis\\ in\\ an\\ immunosuppressed\\ patient\\.\ \(0\)\
\-\ 65\\-year\\-old\\ woman\\ with\\ metastatic\\ breast\\ carcinoma\\ and\\ dysphagia\\.\\ \\ look\\ at\\ films\\ \\.1\\ and\\ \\.2\\.\\ \\ what\\ is\\ the\\ diagnosis\\?\ \(0\)\
\-\ barium\\ studies\\ of\\ the\\ pharynx\\ are\\ usually\\ of\\ limited\\ value\\ in\\ patients\\ with\\ acute\\ sore\\ throat\\ due\\ to\\ viral\\,\\ bacterial\\,\\ or\\ fungal\\ infection\\.\\ \\ such\\ patients\\ usually\\ have\\ normal\\ pharyngograms\\ or\\ nonspecific\\ lymphoid\\ hyperplasia\\ of\\ the\\ palatine\\ or\\ lingual\\ tonsils\\.\\ a\\ double\\ contrast\\ examination\\ of\\ the\\ pharynx\\,\\ however\\,\\ may\\ demonstrate\\ the\\ plaques\\ of\\ candida\\ pharyngitis\\ or\\ the\\ ulcers\\ of\\ herpes\\ pharyngitis\\,\\ particularly\\ in\\ immunosuppressed\\ patients\\ and\\/or\\ patients\\ with\\ acquired\\ immunodeficiency\\ syndrome\\ \\(aids\\)\\.\\ \\ barium\\ studies\\ may\\ also\\ be\\ helpful\\ to\\ determine\\ whether\\ there\\ is\\ underlying\\ gastroesophageal\\ reflux\\ or\\ reflux\\ esophagitis\\ in\\ patients\\ who\\ have\\ chronic\\ sore\\ throat\\.\ \(0\)\
\-\ inflammatory\\ disorders\\ of\\ the\\ pharynx\\ can\\ alter\\ pharyngeal\\ elevation\\,\\ epiglottic\\ tilt\\ or\\ vocal\\ cord\\ and\\ laryngeal\\ vestibule\\ closure\\.\\ \\ thus\\,\\ pharyngeal\\ dysmotility\\ due\\ to\\ a\\ local\\ inflammatory\\ process\\ may\\ result\\ in\\ laryngeal\\ penetration\\,\\ as\\ in\\ this\\ case\\.\\ pharyngeal\\ dysmotility\\ is\\ common\\ following\\ radiation\\ therapy\\ or\\ in\\ patients\\ with\\ marked\\ gastroesophageal\\ reflux\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pharynx\\:\\ 0\\.09209536384000092\ \(0\)\
\-\ pharyngitis\\:\\ 0\\.08081892088130806\ \(0\)\
\-\ candida\\:\\ 0\\.07447778557857056\ \(0\)\
\-\ laryngeal\\:\\ 0\\.07185256732781516\ \(0\)\
\-\ pharyngeal\\:\\ 0\\.06584285410703879\ \(0\)\
\-\ immunosuppressed\\:\\ 0\\.058268424022326334\ \(0\)\
\-\ dysmotility\\:\\ 0\\.05651827852182273\ \(0\)\
\-\ vestibule\\:\\ 0\\.052831975547346366\ \(0\)\
\-\ patients\\:\\ 0\\.05203704939684767\ \(0\)\
\-\ \\.1\\:\\ 0\\.05108183004684276\ \(0\)\
\-\ barium\\:\\ 0\\.04873752458240696\ \(0\)\
\-\ reflux\\:\\ 0\\.04644687027659901\ \(0\)\
\-\ esophagitis\\:\\ 0\\.04604768192000046\ \(0\)\
\-\ sore\\:\\ 0\\.04358762263486287\ \(0\)\
\-\ gastroesophageal\\:\\ 0\\.04082039616723352\ \(0\)\
\-\ throat\\:\\ 0\\.03830347287248762\ \(0\)\
\-\ plaques\\:\\ 0\\.037431114950054495\ \(0\)\
\-\ \\.2\\.\\:\\ 0\\.03457066048614313\ \(0\)\
\-\ pharyngograms\\:\\ 0\\.03457066048614313\ \(0\)\
\-\ epiglottic\\:\\ 0\\.03457066048614313\ \(0\)\
\-\ palatine\\:\\ 0\\.03185243624865315\ \(0\)\
\-\ phonation\\:\\ 0\\.029134212011163167\ \(0\)\
\-\ coated\\:\\ 0\\.029134212011163167\ \(0\)\
\-\ 65\\-year\\-old\\:\\ 0\\.029134212011163167\ \(0\)\
\-\ immunodeficiency\\:\\ 0\\.029134212011163167\ \(0\)\
\-\ films\\:\\ 0\\.027664716809976182\ \(0\)\
\-\ or\\:\\ 0\\.027492781344101776\ \(0\)\
\-\ aligned\\:\\ 0\\.026939640293769353\ \(0\)\
\-\ \\.3\\:\\ 0\\.026415987773673183\ \(0\)\
\-\ lingual\\:\\ 0\\.026415987773673183\ \(0\)\
\-\ longitudinally\\:\\ 0\\.02595409351619717\ \(0\)\
\-\ tilt\\:\\ 0\\.02595409351619717\ \(0\)\
\-\ alter\\:\\ 0\\.02554091502342138\ \(0\)\
\-\ view\\:\\ 0\\.02514546375514932\ \(0\)\
\-\ studies\\:\\ 0\\.025031379747287526\ \(0\)\
\-\ 2\\-4\\:\\ 0\\.024825928526190186\ \(0\)\
\-\ \\.2\\:\\ 0\\.024825928526190186\ \(0\)\
\-\ lymphoid\\:\\ 0\\.023697763536183202\ \(0\)\
\-\ inflammatory\\:\\ 0\\.02324169367993744\ \(0\)\
\-\ vocal\\:\\ 0\\.023235869278707192\ \(0\)\
\-\ tonsillar\\:\\ 0\\.02302384096000023\ \(0\)\
\-\ penetration\\:\\ 0\\.022107704288700205\ \(0\)\
\-\ may\\:\\ 0\\.022050921987036752\ \(0\)\
\-\ herpes\\:\\ 0\\.02164581003122419\ \(0\)\
\-\ tonsils\\:\\ 0\\.021104043997966088\ \(0\)\
\-\ oropharynx\\:\\ 0\\.02097953929869322\ \(0\)\
\-\ aids\\:\\ 0\\.02097953929869322\ \(0\)\
\-\ usually\\:\\ 0\\.02035237846170007\ \(0\)\
\-\ folds\\:\\ 0\\.020305616722510245\ \(0\)\
\-\ closure\\:\\ 0\\.019820856110874256\ \(0\)\
\-\ ulcers\\:\\ 0\\.019730701137444066\ \(0\)\
\-\ value\\:\\ 0\\.01900088827613481\ \(0\)\
\-\ look\\:\\ 0\\.018647354562431682\ \(0\)\
\-\ shows\\:\\ 0\\.01842646039003042\ \(0\)\
\-\ whether\\:\\ 0\\.018023571446236827\ \(0\)\
\-\ acquired\\:\\ 0\\.017966321252428388\ \(0\)\
\-\ due\\:\\ 0\\.017884526689826194\ \(0\)\
\-\ trachea\\:\\ 0\\.017799420803727227\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.017745329344384733\ \(0\)\
\-\ what\\:\\ 0\\.017691973846126776\ \(0\)\
\-\ helpful\\:\\ 0\\.017337526546251213\ \(0\)\
\-\ mucosal\\:\\ 0\\.017289408536087236\ \(0\)\
\-\ particularly\\:\\ 0\\.017289408536087236\ \(0\)\
\-\ nonspecific\\:\\ 0\\.017241873788901567\ \(0\)\
\-\ bacterial\\:\\ 0\\.017148498695985025\ \(0\)\
\-\ determine\\:\\ 0\\.016968164918566113\ \(0\)\
\-\ viral\\:\\ 0\\.01688101536254764\ \(0\)\
\-\ thus\\:\\ 0\\.016671255813720243\ \(0\)\
\-\ elevation\\:\\ 0\\.016550582642478072\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.01651116956069963\ \(0\)\
\-\ dysphagia\\:\\ 0\\.016319835583564608\ \(0\)\
\-\ fungal\\:\\ 0\\.016245841527468986\ \(0\)\
\-\ double\\:\\ 0\\.01620936155624423\ \(0\)\
\-\ disorders\\:\\ 0\\.01603188472648689\ \(0\)\
\-\ local\\:\\ 0\\.01539282076762645\ \(0\)\
\-\ in\\:\\ 0\\.01487284341671488\ \(0\)\
\-\ esophagus\\:\\ 0\\.014547344902219284\ \(0\)\
\-\ have\\:\\ 0\\.014513239830314445\ \(0\)\
\-\ underlying\\:\\ 0\\.0143616738410538\ \(0\)\
\-\ and\\/or\\:\\ 0\\.014162791125057658\ \(0\)\
\-\ limited\\:\\ 0\\.014141303024019912\ \(0\)\
\-\ multiple\\:\\ 0\\.014116125517484462\ \(0\)\
\-\ mid\\:\\ 0\\.014014789838850414\ \(0\)\
\-\ nodules\\:\\ 0\\.013892230844716672\ \(0\)\
\-\ fossa\\:\\ 0\\.013658037767455408\ \(0\)\
\-\ single\\:\\ 0\\.013582981531335026\ \(0\)\
\-\ irregular\\:\\ 0\\.013366065303946587\ \(0\)\
\-\ \\?\\:\\ 0\\.013077958825978458\ \(0\)\
\-\ marked\\:\\ 0\\.013077958825978458\ \(0\)\
\-\ process\\:\\ 0\\.012902217587587115\ \(0\)\
\-\ film\\:\\ 0\\.012871093863682266\ \(0\)\
\-\ result\\:\\ 0\\.012855624144893968\ \(0\)\
\-\ cord\\:\\ 0\\.012734015373354515\ \(0\)\
\-\ breast\\:\\ 0\\.012362972328747264\ \(0\)\
\-\ mm\\:\\ 0\\.012322333948215707\ \(0\)\
\-\ \\,\\:\\ 0\\.01167768910074573\ \(0\)\
\-\ along\\:\\ 0\\.011074721085719672\ \(0\)\
\-\ radiation\\:\\ 0\\.010997063723773869\ \(0\)\
\-\ such\\:\\ 0\\.01047581486212099\ \(0\)\
\-\ examination\\:\\ 0\\.010417345237155158\ \(0\)\
\-\ during\\:\\ 0\\.010254938234995325\ \(0\)\
\-\ infection\\:\\ 0\\.009741241466952185\ \(0\)\
\-\ syndrome\\:\\ 0\\.009583947359743692\ \(0\)\
\-\ following\\:\\ 0\\.009510893164318229\ \(0\)\
\-\ carcinoma\\:\\ 0\\.009497755568689672\ \(0\)\
\-\ chronic\\:\\ 0\\.009439175031007843\ \(0\)\
\-\ however\\:\\ 0\\.009330855119988511\ \(0\)\
\-\ therapy\\:\\ 0\\.008959375671531815\ \(0\)\
\-\ common\\:\\ 0\\.008769675341005478\ \(0\)\
\-\ who\\:\\ 0\\.008737131016241968\ \(0\)\
\-\ \\(\\:\\ 0\\.008498373249927771\ \(0\)\
\-\ metastatic\\:\\ 0\\.008435723151435648\ \(0\)\
\-\ \\)\\:\\ 0\\.008394561083685942\ \(0\)\
\-\ acute\\:\\ 0\\.008274036584731354\ \(0\)\
\-\ woman\\:\\ 0\\.007740795872505515\ \(0\)\
\-\ small\\:\\ 0\\.007719903076004387\ \(0\)\
\-\ demonstrate\\:\\ 0\\.007711577024835454\ \(0\)\
\-\ diagnosis\\:\\ 0\\.007694977767766353\ \(0\)\
\-\ can\\:\\ 0\\.00760087197046694\ \(0\)\
\-\ contrast\\:\\ 0\\.007501081124736884\ \(0\)\
\-\ case\\:\\ 0\\.007331389932812827\ \(0\)\
\-\ lateral\\:\\ 0\\.007241835473037452\ \(0\)\
\-\ is\\:\\ 0\\.006615185628055595\ \(0\)\
\-\ also\\:\\ 0\\.006606351347726084\ \(0\)\
\-\ the\\:\\ 0\\.006505848691935332\ \(0\)\
\-\ has\\:\\ 0\\.0062929410607618745\ \(0\)\
\-\ a\\:\\ 0\\.006221173361860412\ \(0\)\
\-\ normal\\:\\ 0\\.005253382174898435\ \(0\)\
\-\ be\\:\\ 0\\.005167673424878154\ \(0\)\
\-\ as\\:\\ 0\\.005068931395663247\ \(0\)\
\-\ to\\:\\ 0\\.005024330687564544\ \(0\)\
\-\ there\\:\\ 0\\.004987119829274465\ \(0\)\
\-\ and\\:\\ 0\\.004941423686766781\ \(0\)\
\-\ an\\:\\ 0\\.004633979859940117\ \(0\)\
\-\ are\\:\\ 0\\.004568132833449419\ \(0\)\
\-\ at\\:\\ 0\\.004540247658163267\ \(0\)\
\-\ of\\:\\ 0\\.00411189885169371\ \(0\)\
\-\ this\\:\\ 0\\.003769165542408365\ \(0\)\
\-\ patient\\:\\ 0\\.0033591840428093644\ \(0\)\
\-\ with\\:\\ 0\\.0018353596249394467\ \(0\)\
\-\ \\.\\:\\ 0\\.0016705664045810011\ \(0\)\
